Sarah J. Zardawi

Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer Patients

Elena López‐Knowles, Sarah J. Zardawi, Catriona M. McNeil et al. · Cancer Epidemiology Biomarkers & Prevention · 2010 · 147 citations · Full text

Medicine, Cell Biology, Oncology +12

High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype

Sarah J. Zardawi, Ibrahim M. Zardawi, Catriona M. McNeil et al. · Histopathology · 2010 · 62 citations

Medicine, Molecular Biology, Oncology +17

Localized malignant pleural mesothelioma with renal metastasis

Sarah J. Zardawi, Bob T. Li, Marjorie G. Zauderer et al. · Oxford Medical Case Reports · 2015 · 11 citations · Full text

Medicine, Oncology, Pathology +16

Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61–20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial

Nicholas Zdenkowski, Marion Kuper‐Hommel, Samuel M. Niman et al. · The Lancet Oncology · 2025 · 10 citations

Medicine, Oncology, Pharmacology +17